Bio-Sight Capital
Overview
Bio-Sight Capital is a venture capital firm based in Japan that focuses on long-term investments in the biotechnology and deep-tech sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ai-BrainScience Inc. | Mar 2026 | VC Round | Co-investor |
| LQUOM | Apr 2026 | Series B | Co-investor |
| EneCoat Technologies | Mar 2023 | Series B Extension | Co-investor |
| Waqua Inc. | Jul 2024 | VC Round | Co-investor |
| SCOHIA PHARMA, Inc. | May 2026 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bio-Sight Capital based?
Bio-Sight Capital is headquartered in Ibaraki, Japan.
When was Bio-Sight Capital founded?
Bio-Sight Capital was founded in 2002.
How many portfolio companies does Bio-Sight Capital have?
Bio-Sight Capital has 9 portfolio companies in Caplight's dataset.
What are some companies in Bio-Sight Capital's portfolio?
Portfolio companies visible on Caplight include Ai-BrainScience Inc., LQUOM, EneCoat Technologies, Waqua Inc., SCOHIA PHARMA, Inc..
What was Bio-Sight Capital's most recent investment shown here?
Bio-Sight Capital's most recent investment in this portfolio sample was in SCOHIA PHARMA, Inc. in 2026.
What sectors does Bio-Sight Capital focus on?
Bio-Sight Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Enterprise Software, Telecommunications & Networking, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Bio-Sight Capital focus on?
Bio-Sight Capital typically invests at the MultiStage stage.